关于 "Cancer stem cell" 的结果14+ 个结果

筛选:Chromatin/Epigenetics×
  • GC12781 structure
    XAV-939
    CAS: 284028-89-3

    XAV-939 选择性抑制 β-连环蛋白介导的转录。

  • GC12961 structure
    Apicidin
    CAS: 183506-66-3

    A cell-permeable HDAC inhibitor

  • GC17534 structure
    GSK343
    CAS: 1346704-33-3

    A selective, cell-permeable EZH2 inhibitor

  • GC65019 structure
    SRT 1460
    CAS: 925432-73-1

    SRT-1460 is a potent and selective activator of Sirtuin 1 (SIRT1) with EC1.5 of 2.9 μM. SRT-1460 reduces cell viability and growth of pancreatic cancer cells and induces apoptosis.

  • GC63694 structure
    BAZ1A-IN-1
    CAS: 941521-45-5

    BAZ1A-IN-1 is a potent inhibitor of BAZ1A (bromodomain-containing protein), exerting a Kd value of 0.52 μM against BAZ1A bromodomain, shows good anti-viability activity against cancer cell lines expressing a high level of BAZ1A, but weak or no activity against cancer cells with a low expression level of BAZ1A.

  • GC66067 structure
    ODM-207
    CAS: 1801503-93-4

    ODM-207 is a potent and selective BET inhibitor that is structurally unrelated to the benzodiazepine. ODM-207 also shows potent antiproliferative effects in patient-derived cancer cells and in xenograft models.

  • GC32948 structure
    IDF-11774
    CAS: 1429054-28-3

    IDF-11774 is a hypoxia-inducible factor-1 (HIF-1) inhibitor. It reduces the HRE-luciferase activity of HIF-1α (IC50 = 3.65 μM) and blocks HIF-1α accumulation under hypoxia in HCT116 human colon cancer cells.

  • GC36855 structure
    Paris saponin VII
    CAS: 68124-04-9

    Chonglou Saponin VII (Dioscinin, Polyphyllin-VII, Paris saponin-VII), a kind of steroidal saponins from Chonglou (Rhizoma Paridis Chonglou), inhibits EMT and reduces the invasion of ovarian cancer cells via the GSK-3β/β-catenin signaling pathway.

  • GC25305 structure
    CPI-455 HCl
    CAS: 2095432-28-1

    CPI-455 HCl is a specific KDM5 inhibitor with a half-maximal inhibitory concentration (IC50) of 10 ± 1 nM for full-length KDM5A in enzymatic assays, elevating global levels of H3K4 trimethylation (H3K4me3) and decreased the number of DTPs in multiple cancer cell line models treated with standard chemotherapy or targeted agents.This product has poor solubility, animal experiments are available, cell experiments please choose carefully!

  • GC62129 structure
    Venadaparib
    CAS: 1681017-83-3

    Venadaparib (IDX-1197), a potent PARP1/2 inhibitor with IC50 values of 1.4 nM and 1.0 nM respectively, prevents the repair of DNA single-strand breaks (SSB) and promotes the conversion of SSB to double-stranded breaks (DSB), which ultimately leads to synthetic lethality in cancer cells.

  • GC34849 structure
    UBCS039
    CAS: 358721-70-7

    UBCS039 is the first synthetic SIRT6 activator with EC50 of 38 μM,induces a time-dependent activation of autophagy in several human tumor cell lines.

  • GC15040 structure
    NSC 3852
    CAS: 3565-26-2

    A tumor cell differentiating agent

  • GC44184 structure
    Methylstat (hydrate)

    A cell-permeable demethylase inhibitor

  • GC13764 structure
    Nexturastat A
    CAS: 1403783-31-2

    A potent, cell-permeable HDAC6 inhibitor